nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—testicular cancer	0.214	1	CrCtD
Epirubicin—Anthracyclines—Doxorubicin—testicular cancer	0.124	0.427	CiPCiCtD
Epirubicin—Topoisomerase Inhibitors—Etoposide—testicular cancer	0.101	0.35	CiPCiCtD
Epirubicin—Topoisomerase Inhibitors—Doxorubicin—testicular cancer	0.0646	0.223	CiPCiCtD
Epirubicin—urinary bladder cancer—testicular cancer	0.0521	0.286	CtDrD
Epirubicin—prostate cancer—testicular cancer	0.0509	0.279	CtDrD
Epirubicin—Daunorubicin—Doxorubicin—testicular cancer	0.0452	0.333	CrCrCtD
Epirubicin—Valrubicin—Doxorubicin—testicular cancer	0.0452	0.333	CrCrCtD
Epirubicin—Idarubicin—Doxorubicin—testicular cancer	0.0452	0.333	CrCrCtD
Epirubicin—ovarian cancer—testicular cancer	0.0441	0.242	CtDrD
Epirubicin—sarcoma—testicular cancer	0.0352	0.193	CtDrD
Epirubicin—DHCR7—Doxorubicin—testicular cancer	0.0284	0.229	CbGbCtD
Epirubicin—YWHAG—Doxorubicin—testicular cancer	0.0284	0.229	CbGbCtD
Epirubicin—AURKA—Doxorubicin—testicular cancer	0.0284	0.229	CbGbCtD
Epirubicin—TOP2A—Etoposide—testicular cancer	0.00847	0.0682	CbGbCtD
Epirubicin—ABCC1—Dactinomycin—testicular cancer	0.00832	0.067	CbGbCtD
Epirubicin—TOP2A—Doxorubicin—testicular cancer	0.00578	0.0465	CbGbCtD
Epirubicin—ABCC1—Vinblastine—testicular cancer	0.00521	0.042	CbGbCtD
Epirubicin—ABCC1—Etoposide—testicular cancer	0.0047	0.0378	CbGbCtD
Epirubicin—ABCC1—Doxorubicin—testicular cancer	0.0032	0.0258	CbGbCtD
Epirubicin—ABCC1—Methotrexate—testicular cancer	0.0031	0.025	CbGbCtD
Epirubicin—CHD1—seminal vesicle—testicular cancer	0.0008	0.0842	CbGeAlD
Epirubicin—CHD1—gonad—testicular cancer	0.000578	0.0608	CbGeAlD
Epirubicin—DHCR7—seminal vesicle—testicular cancer	0.00054	0.0568	CbGeAlD
Epirubicin—YWHAG—seminal vesicle—testicular cancer	0.000495	0.0521	CbGeAlD
Epirubicin—CHD1—female gonad—testicular cancer	0.00047	0.0494	CbGeAlD
Epirubicin—AURKA—gonad—testicular cancer	0.000466	0.049	CbGeAlD
Epirubicin—CHD1—testis—testicular cancer	0.000417	0.0438	CbGeAlD
Epirubicin—DHCR7—gonad—testicular cancer	0.00039	0.041	CbGeAlD
Epirubicin—AURKA—female gonad—testicular cancer	0.000379	0.0398	CbGeAlD
Epirubicin—PLA2G4A—seminal vesicle—testicular cancer	0.000369	0.0388	CbGeAlD
Epirubicin—YWHAG—gonad—testicular cancer	0.000358	0.0376	CbGeAlD
Epirubicin—AURKA—testis—testicular cancer	0.000336	0.0353	CbGeAlD
Epirubicin—DHCR7—female gonad—testicular cancer	0.000317	0.0333	CbGeAlD
Epirubicin—CHD1—lymph node—testicular cancer	0.000302	0.0318	CbGeAlD
Epirubicin—YWHAG—female gonad—testicular cancer	0.000291	0.0306	CbGeAlD
Epirubicin—DHCR7—testis—testicular cancer	0.000281	0.0296	CbGeAlD
Epirubicin—YWHAG—testis—testicular cancer	0.000258	0.0271	CbGeAlD
Epirubicin—AURKA—lymph node—testicular cancer	0.000244	0.0256	CbGeAlD
Epirubicin—UGT2B7—testis—testicular cancer	0.000233	0.0245	CbGeAlD
Epirubicin—PLA2G4A—female gonad—testicular cancer	0.000217	0.0228	CbGeAlD
Epirubicin—ABCC1—seminal vesicle—testicular cancer	0.000211	0.0222	CbGeAlD
Epirubicin—TOP2A—female gonad—testicular cancer	0.000206	0.0217	CbGeAlD
Epirubicin—DHCR7—lymph node—testicular cancer	0.000204	0.0214	CbGeAlD
Epirubicin—PLA2G4A—testis—testicular cancer	0.000192	0.0202	CbGeAlD
Epirubicin—YWHAG—lymph node—testicular cancer	0.000187	0.0197	CbGeAlD
Epirubicin—TOP2A—testis—testicular cancer	0.000183	0.0192	CbGeAlD
Epirubicin—PLA2G4A—lymph node—testicular cancer	0.000139	0.0147	CbGeAlD
Epirubicin—TOP2A—lymph node—testicular cancer	0.000132	0.0139	CbGeAlD
Epirubicin—CHD1—Daunorubicin—Doxorubicin—testicular cancer	0.000131	0.168	CbGdCrCtD
Epirubicin—CHD1—Idarubicin—Doxorubicin—testicular cancer	0.000131	0.168	CbGdCrCtD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—testicular cancer	0.000126	0.161	CbGdCrCtD
Epirubicin—ABCC1—female gonad—testicular cancer	0.000124	0.013	CbGeAlD
Epirubicin—ABCC1—testis—testicular cancer	0.00011	0.0116	CbGeAlD
Epirubicin—AURKA—Teniposide—Etoposide—testicular cancer	8.95e-05	0.114	CbGdCrCtD
Epirubicin—ABCC1—lymph node—testicular cancer	7.98e-05	0.00839	CbGeAlD
Epirubicin—TOP2A—Vindesine—Vinblastine—testicular cancer	5.42e-05	0.0692	CbGdCrCtD
Epirubicin—AURKA—Idarubicin—Doxorubicin—testicular cancer	4.32e-05	0.0551	CbGdCrCtD
Epirubicin—AURKA—Daunorubicin—Doxorubicin—testicular cancer	4.32e-05	0.0551	CbGdCrCtD
Epirubicin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	3.42e-05	0.0437	CbGdCrCtD
Epirubicin—TOP2A—Podofilox—Etoposide—testicular cancer	3.42e-05	0.0436	CbGdCrCtD
Epirubicin—TOP2A—Teniposide—Etoposide—testicular cancer	3.42e-05	0.0436	CbGdCrCtD
Epirubicin—TOP2A—Vincristine—Vinblastine—testicular cancer	2.92e-05	0.0373	CbGdCrCtD
Epirubicin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	1.65e-05	0.0211	CbGdCrCtD
Epirubicin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	1.65e-05	0.0211	CbGdCrCtD
Epirubicin—Pain—Cisplatin—testicular cancer	7.98e-06	0.000181	CcSEcCtD
Epirubicin—Dermatitis—Bleomycin—testicular cancer	7.97e-06	0.00018	CcSEcCtD
Epirubicin—Hypersensitivity—Ifosfamide—testicular cancer	7.97e-06	0.00018	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	7.96e-06	0.00018	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	7.95e-06	0.00018	CcSEcCtD
Epirubicin—Muscular weakness—Doxorubicin—testicular cancer	7.95e-06	0.00018	CcSEcCtD
Epirubicin—Renal failure—Methotrexate—testicular cancer	7.89e-06	0.000179	CcSEcCtD
Epirubicin—Abdominal distension—Doxorubicin—testicular cancer	7.84e-06	0.000178	CcSEcCtD
Epirubicin—Stomatitis—Methotrexate—testicular cancer	7.82e-06	0.000177	CcSEcCtD
Epirubicin—Conjunctivitis—Methotrexate—testicular cancer	7.8e-06	0.000177	CcSEcCtD
Epirubicin—Asthma—Doxorubicin—testicular cancer	7.79e-06	0.000176	CcSEcCtD
Epirubicin—Dysphagia—Doxorubicin—testicular cancer	7.79e-06	0.000176	CcSEcCtD
Epirubicin—Influenza—Doxorubicin—testicular cancer	7.79e-06	0.000176	CcSEcCtD
Epirubicin—Asthenia—Ifosfamide—testicular cancer	7.76e-06	0.000176	CcSEcCtD
Epirubicin—Eosinophilia—Doxorubicin—testicular cancer	7.72e-06	0.000175	CcSEcCtD
Epirubicin—Sweating—Methotrexate—testicular cancer	7.69e-06	0.000174	CcSEcCtD
Epirubicin—Feeling abnormal—Cisplatin—testicular cancer	7.69e-06	0.000174	CcSEcCtD
Epirubicin—Paraesthesia—Etoposide—testicular cancer	7.67e-06	0.000174	CcSEcCtD
Epirubicin—Pruritus—Ifosfamide—testicular cancer	7.65e-06	0.000173	CcSEcCtD
Epirubicin—Haematuria—Methotrexate—testicular cancer	7.65e-06	0.000173	CcSEcCtD
Epirubicin—Pancreatitis—Doxorubicin—testicular cancer	7.64e-06	0.000173	CcSEcCtD
Epirubicin—Dyspnoea—Etoposide—testicular cancer	7.62e-06	0.000172	CcSEcCtD
Epirubicin—Somnolence—Etoposide—testicular cancer	7.6e-06	0.000172	CcSEcCtD
Epirubicin—Angina pectoris—Doxorubicin—testicular cancer	7.59e-06	0.000172	CcSEcCtD
Epirubicin—Hepatobiliary disease—Methotrexate—testicular cancer	7.59e-06	0.000172	CcSEcCtD
Epirubicin—Epistaxis—Methotrexate—testicular cancer	7.57e-06	0.000171	CcSEcCtD
Epirubicin—Nausea—Bleomycin—testicular cancer	7.52e-06	0.00017	CcSEcCtD
Epirubicin—Vomiting—Dactinomycin—testicular cancer	7.51e-06	0.00017	CcSEcCtD
Epirubicin—Bronchitis—Doxorubicin—testicular cancer	7.49e-06	0.00017	CcSEcCtD
Epirubicin—Agranulocytosis—Methotrexate—testicular cancer	7.49e-06	0.000169	CcSEcCtD
Epirubicin—Rash—Dactinomycin—testicular cancer	7.44e-06	0.000168	CcSEcCtD
Epirubicin—Decreased appetite—Etoposide—testicular cancer	7.43e-06	0.000168	CcSEcCtD
Epirubicin—Diarrhoea—Ifosfamide—testicular cancer	7.4e-06	0.000168	CcSEcCtD
Epirubicin—Pancytopenia—Doxorubicin—testicular cancer	7.4e-06	0.000167	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Etoposide—testicular cancer	7.38e-06	0.000167	CcSEcCtD
Epirubicin—Body temperature increased—Cisplatin—testicular cancer	7.37e-06	0.000167	CcSEcCtD
Epirubicin—Fatigue—Etoposide—testicular cancer	7.37e-06	0.000167	CcSEcCtD
Epirubicin—Pain—Etoposide—testicular cancer	7.31e-06	0.000165	CcSEcCtD
Epirubicin—Constipation—Etoposide—testicular cancer	7.31e-06	0.000165	CcSEcCtD
Epirubicin—Neutropenia—Doxorubicin—testicular cancer	7.29e-06	0.000165	CcSEcCtD
Epirubicin—Dysuria—Doxorubicin—testicular cancer	7.29e-06	0.000165	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Doxorubicin—testicular cancer	7.24e-06	0.000164	CcSEcCtD
Epirubicin—Haemoglobin—Methotrexate—testicular cancer	7.24e-06	0.000164	CcSEcCtD
Epirubicin—Haemorrhage—Methotrexate—testicular cancer	7.2e-06	0.000163	CcSEcCtD
Epirubicin—Hepatitis—Methotrexate—testicular cancer	7.2e-06	0.000163	CcSEcCtD
Epirubicin—Pollakiuria—Doxorubicin—testicular cancer	7.2e-06	0.000163	CcSEcCtD
Epirubicin—Dizziness—Ifosfamide—testicular cancer	7.15e-06	0.000162	CcSEcCtD
Epirubicin—Pharyngitis—Methotrexate—testicular cancer	7.15e-06	0.000162	CcSEcCtD
Epirubicin—Urinary tract disorder—Methotrexate—testicular cancer	7.11e-06	0.000161	CcSEcCtD
Epirubicin—Photosensitivity reaction—Doxorubicin—testicular cancer	7.11e-06	0.000161	CcSEcCtD
Epirubicin—Weight increased—Doxorubicin—testicular cancer	7.09e-06	0.000161	CcSEcCtD
Epirubicin—Urethral disorder—Methotrexate—testicular cancer	7.06e-06	0.00016	CcSEcCtD
Epirubicin—Weight decreased—Doxorubicin—testicular cancer	7.05e-06	0.00016	CcSEcCtD
Epirubicin—Feeling abnormal—Etoposide—testicular cancer	7.04e-06	0.000159	CcSEcCtD
Epirubicin—Hyperglycaemia—Doxorubicin—testicular cancer	7.03e-06	0.000159	CcSEcCtD
Epirubicin—Nausea—Dactinomycin—testicular cancer	7.01e-06	0.000159	CcSEcCtD
Epirubicin—Pneumonia—Doxorubicin—testicular cancer	6.99e-06	0.000158	CcSEcCtD
Epirubicin—Gastrointestinal pain—Etoposide—testicular cancer	6.99e-06	0.000158	CcSEcCtD
Epirubicin—Drowsiness—Doxorubicin—testicular cancer	6.95e-06	0.000157	CcSEcCtD
Epirubicin—Infestation—Doxorubicin—testicular cancer	6.95e-06	0.000157	CcSEcCtD
Epirubicin—Infestation NOS—Doxorubicin—testicular cancer	6.95e-06	0.000157	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—testicular cancer	6.94e-06	0.000157	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	6.89e-06	0.000156	CcSEcCtD
Epirubicin—Vomiting—Ifosfamide—testicular cancer	6.88e-06	0.000156	CcSEcCtD
Epirubicin—Hypersensitivity—Cisplatin—testicular cancer	6.87e-06	0.000156	CcSEcCtD
Epirubicin—Renal failure—Doxorubicin—testicular cancer	6.83e-06	0.000155	CcSEcCtD
Epirubicin—Rash—Ifosfamide—testicular cancer	6.82e-06	0.000154	CcSEcCtD
Epirubicin—Dermatitis—Ifosfamide—testicular cancer	6.81e-06	0.000154	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—testicular cancer	6.81e-06	0.000154	CcSEcCtD
Epirubicin—Neuropathy peripheral—Doxorubicin—testicular cancer	6.81e-06	0.000154	CcSEcCtD
Epirubicin—Urticaria—Etoposide—testicular cancer	6.79e-06	0.000154	CcSEcCtD
Epirubicin—Jaundice—Doxorubicin—testicular cancer	6.77e-06	0.000153	CcSEcCtD
Epirubicin—Stomatitis—Doxorubicin—testicular cancer	6.77e-06	0.000153	CcSEcCtD
Epirubicin—Abdominal pain—Etoposide—testicular cancer	6.75e-06	0.000153	CcSEcCtD
Epirubicin—Body temperature increased—Etoposide—testicular cancer	6.75e-06	0.000153	CcSEcCtD
Epirubicin—Conjunctivitis—Doxorubicin—testicular cancer	6.75e-06	0.000153	CcSEcCtD
Epirubicin—Urinary tract infection—Doxorubicin—testicular cancer	6.75e-06	0.000153	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—testicular cancer	6.73e-06	0.000152	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—testicular cancer	6.72e-06	0.000152	CcSEcCtD
Epirubicin—Asthenia—Cisplatin—testicular cancer	6.69e-06	0.000151	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—testicular cancer	6.69e-06	0.000151	CcSEcCtD
Epirubicin—Sweating—Doxorubicin—testicular cancer	6.66e-06	0.000151	CcSEcCtD
Epirubicin—Haematuria—Doxorubicin—testicular cancer	6.62e-06	0.00015	CcSEcCtD
Epirubicin—Hepatobiliary disease—Doxorubicin—testicular cancer	6.57e-06	0.000149	CcSEcCtD
Epirubicin—Epistaxis—Doxorubicin—testicular cancer	6.55e-06	0.000148	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—testicular cancer	6.54e-06	0.000148	CcSEcCtD
Epirubicin—Sinusitis—Doxorubicin—testicular cancer	6.52e-06	0.000148	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—testicular cancer	6.51e-06	0.000147	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—testicular cancer	6.49e-06	0.000147	CcSEcCtD
Epirubicin—Agranulocytosis—Doxorubicin—testicular cancer	6.48e-06	0.000147	CcSEcCtD
Epirubicin—Chills—Methotrexate—testicular cancer	6.46e-06	0.000146	CcSEcCtD
Epirubicin—Nausea—Ifosfamide—testicular cancer	6.43e-06	0.000145	CcSEcCtD
Epirubicin—Diarrhoea—Cisplatin—testicular cancer	6.38e-06	0.000144	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—testicular cancer	6.37e-06	0.000144	CcSEcCtD
Epirubicin—Bradycardia—Doxorubicin—testicular cancer	6.35e-06	0.000144	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—testicular cancer	6.31e-06	0.000143	CcSEcCtD
Epirubicin—Hypersensitivity—Etoposide—testicular cancer	6.29e-06	0.000142	CcSEcCtD
Epirubicin—Erythema—Methotrexate—testicular cancer	6.27e-06	0.000142	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—testicular cancer	6.27e-06	0.000142	CcSEcCtD
Epirubicin—Haemoglobin—Doxorubicin—testicular cancer	6.27e-06	0.000142	CcSEcCtD
Epirubicin—Rhinitis—Doxorubicin—testicular cancer	6.25e-06	0.000142	CcSEcCtD
Epirubicin—Haemorrhage—Doxorubicin—testicular cancer	6.24e-06	0.000141	CcSEcCtD
Epirubicin—Hepatitis—Doxorubicin—testicular cancer	6.24e-06	0.000141	CcSEcCtD
Epirubicin—Hypoaesthesia—Doxorubicin—testicular cancer	6.21e-06	0.00014	CcSEcCtD
Epirubicin—Pharyngitis—Doxorubicin—testicular cancer	6.19e-06	0.00014	CcSEcCtD
Epirubicin—Urinary tract disorder—Doxorubicin—testicular cancer	6.16e-06	0.000139	CcSEcCtD
Epirubicin—Oedema peripheral—Doxorubicin—testicular cancer	6.14e-06	0.000139	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—testicular cancer	6.14e-06	0.000139	CcSEcCtD
Epirubicin—Asthenia—Etoposide—testicular cancer	6.13e-06	0.000139	CcSEcCtD
Epirubicin—Connective tissue disorder—Doxorubicin—testicular cancer	6.13e-06	0.000139	CcSEcCtD
Epirubicin—Urethral disorder—Doxorubicin—testicular cancer	6.11e-06	0.000138	CcSEcCtD
Epirubicin—Back pain—Methotrexate—testicular cancer	6.07e-06	0.000137	CcSEcCtD
Epirubicin—Pruritus—Etoposide—testicular cancer	6.04e-06	0.000137	CcSEcCtD
Epirubicin—Visual impairment—Doxorubicin—testicular cancer	6.01e-06	0.000136	CcSEcCtD
Epirubicin—Vomiting—Cisplatin—testicular cancer	5.93e-06	0.000134	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—testicular cancer	5.91e-06	0.000134	CcSEcCtD
Epirubicin—Erythema multiforme—Doxorubicin—testicular cancer	5.9e-06	0.000133	CcSEcCtD
Epirubicin—Rash—Cisplatin—testicular cancer	5.88e-06	0.000133	CcSEcCtD
Epirubicin—Dermatitis—Cisplatin—testicular cancer	5.87e-06	0.000133	CcSEcCtD
Epirubicin—Diarrhoea—Etoposide—testicular cancer	5.85e-06	0.000132	CcSEcCtD
Epirubicin—Eye disorder—Doxorubicin—testicular cancer	5.83e-06	0.000132	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—testicular cancer	5.82e-06	0.000132	CcSEcCtD
Epirubicin—Tinnitus—Doxorubicin—testicular cancer	5.82e-06	0.000132	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—testicular cancer	5.8e-06	0.000131	CcSEcCtD
Epirubicin—Flushing—Doxorubicin—testicular cancer	5.79e-06	0.000131	CcSEcCtD
Epirubicin—Cardiac disorder—Doxorubicin—testicular cancer	5.79e-06	0.000131	CcSEcCtD
Epirubicin—Angiopathy—Doxorubicin—testicular cancer	5.66e-06	0.000128	CcSEcCtD
Epirubicin—Malaise—Methotrexate—testicular cancer	5.65e-06	0.000128	CcSEcCtD
Epirubicin—Dizziness—Etoposide—testicular cancer	5.65e-06	0.000128	CcSEcCtD
Epirubicin—Immune system disorder—Doxorubicin—testicular cancer	5.63e-06	0.000128	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—testicular cancer	5.63e-06	0.000128	CcSEcCtD
Epirubicin—Mediastinal disorder—Doxorubicin—testicular cancer	5.62e-06	0.000127	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—testicular cancer	5.61e-06	0.000127	CcSEcCtD
Epirubicin—Chills—Doxorubicin—testicular cancer	5.6e-06	0.000127	CcSEcCtD
Epirubicin—Arrhythmia—Doxorubicin—testicular cancer	5.57e-06	0.000126	CcSEcCtD
Epirubicin—Nausea—Cisplatin—testicular cancer	5.54e-06	0.000125	CcSEcCtD
Epirubicin—Alopecia—Doxorubicin—testicular cancer	5.51e-06	0.000125	CcSEcCtD
Epirubicin—Cough—Methotrexate—testicular cancer	5.47e-06	0.000124	CcSEcCtD
Epirubicin—Mental disorder—Doxorubicin—testicular cancer	5.46e-06	0.000124	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—testicular cancer	5.43e-06	0.000123	CcSEcCtD
Epirubicin—Vomiting—Etoposide—testicular cancer	5.43e-06	0.000123	CcSEcCtD
Epirubicin—Erythema—Doxorubicin—testicular cancer	5.43e-06	0.000123	CcSEcCtD
Epirubicin—Malnutrition—Doxorubicin—testicular cancer	5.43e-06	0.000123	CcSEcCtD
Epirubicin—Rash—Etoposide—testicular cancer	5.39e-06	0.000122	CcSEcCtD
Epirubicin—Dermatitis—Etoposide—testicular cancer	5.38e-06	0.000122	CcSEcCtD
Epirubicin—Headache—Etoposide—testicular cancer	5.35e-06	0.000121	CcSEcCtD
Epirubicin—Flatulence—Doxorubicin—testicular cancer	5.35e-06	0.000121	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—testicular cancer	5.34e-06	0.000121	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—testicular cancer	5.34e-06	0.000121	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—testicular cancer	5.34e-06	0.000121	CcSEcCtD
Epirubicin—Tension—Doxorubicin—testicular cancer	5.33e-06	0.000121	CcSEcCtD
Epirubicin—Dysgeusia—Doxorubicin—testicular cancer	5.32e-06	0.00012	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	5.3e-06	0.00012	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—testicular cancer	5.27e-06	0.000119	CcSEcCtD
Epirubicin—Nervousness—Doxorubicin—testicular cancer	5.27e-06	0.000119	CcSEcCtD
Epirubicin—Back pain—Doxorubicin—testicular cancer	5.25e-06	0.000119	CcSEcCtD
Epirubicin—Muscle spasms—Doxorubicin—testicular cancer	5.22e-06	0.000118	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—testicular cancer	5.16e-06	0.000117	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—testicular cancer	5.12e-06	0.000116	CcSEcCtD
Epirubicin—Vision blurred—Doxorubicin—testicular cancer	5.12e-06	0.000116	CcSEcCtD
Epirubicin—Infection—Methotrexate—testicular cancer	5.08e-06	0.000115	CcSEcCtD
Epirubicin—Nausea—Etoposide—testicular cancer	5.07e-06	0.000115	CcSEcCtD
Epirubicin—Ill-defined disorder—Doxorubicin—testicular cancer	5.04e-06	0.000114	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—testicular cancer	5.02e-06	0.000114	CcSEcCtD
Epirubicin—Anaemia—Doxorubicin—testicular cancer	5.02e-06	0.000114	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—testicular cancer	5.01e-06	0.000113	CcSEcCtD
Epirubicin—Agitation—Doxorubicin—testicular cancer	4.99e-06	0.000113	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—testicular cancer	4.97e-06	0.000113	CcSEcCtD
Epirubicin—Hyperhidrosis—Methotrexate—testicular cancer	4.95e-06	0.000112	CcSEcCtD
Epirubicin—Malaise—Doxorubicin—testicular cancer	4.9e-06	0.000111	CcSEcCtD
Epirubicin—Vertigo—Doxorubicin—testicular cancer	4.88e-06	0.00011	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—testicular cancer	4.88e-06	0.00011	CcSEcCtD
Epirubicin—Syncope—Doxorubicin—testicular cancer	4.87e-06	0.00011	CcSEcCtD
Epirubicin—Leukopenia—Doxorubicin—testicular cancer	4.86e-06	0.00011	CcSEcCtD
Epirubicin—Palpitations—Doxorubicin—testicular cancer	4.8e-06	0.000109	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—testicular cancer	4.78e-06	0.000108	CcSEcCtD
Epirubicin—Loss of consciousness—Doxorubicin—testicular cancer	4.77e-06	0.000108	CcSEcCtD
Epirubicin—Cough—Doxorubicin—testicular cancer	4.74e-06	0.000107	CcSEcCtD
Epirubicin—Convulsion—Doxorubicin—testicular cancer	4.7e-06	0.000106	CcSEcCtD
Epirubicin—Hypertension—Doxorubicin—testicular cancer	4.69e-06	0.000106	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methotrexate—testicular cancer	4.66e-06	0.000106	CcSEcCtD
Epirubicin—Insomnia—Methotrexate—testicular cancer	4.63e-06	0.000105	CcSEcCtD
Epirubicin—Chest pain—Doxorubicin—testicular cancer	4.62e-06	0.000105	CcSEcCtD
Epirubicin—Arthralgia—Doxorubicin—testicular cancer	4.62e-06	0.000105	CcSEcCtD
Epirubicin—Myalgia—Doxorubicin—testicular cancer	4.62e-06	0.000105	CcSEcCtD
Epirubicin—Anxiety—Doxorubicin—testicular cancer	4.61e-06	0.000104	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—testicular cancer	4.6e-06	0.000104	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	4.59e-06	0.000104	CcSEcCtD
Epirubicin—Discomfort—Doxorubicin—testicular cancer	4.57e-06	0.000103	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—testicular cancer	4.56e-06	0.000103	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—testicular cancer	4.55e-06	0.000103	CcSEcCtD
Epirubicin—Dry mouth—Doxorubicin—testicular cancer	4.52e-06	0.000102	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—testicular cancer	4.5e-06	0.000102	CcSEcCtD
Epirubicin—Confusional state—Doxorubicin—testicular cancer	4.47e-06	0.000101	CcSEcCtD
Epirubicin—Decreased appetite—Methotrexate—testicular cancer	4.45e-06	0.000101	CcSEcCtD
Epirubicin—Oedema—Doxorubicin—testicular cancer	4.43e-06	0.0001	CcSEcCtD
Epirubicin—Anaphylactic shock—Doxorubicin—testicular cancer	4.43e-06	0.0001	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Methotrexate—testicular cancer	4.42e-06	0.0001	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—testicular cancer	4.41e-06	9.99e-05	CcSEcCtD
Epirubicin—Infection—Doxorubicin—testicular cancer	4.4e-06	9.96e-05	CcSEcCtD
Epirubicin—Pain—Methotrexate—testicular cancer	4.38e-06	9.9e-05	CcSEcCtD
Epirubicin—Shock—Doxorubicin—testicular cancer	4.36e-06	9.87e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Doxorubicin—testicular cancer	4.35e-06	9.84e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Doxorubicin—testicular cancer	4.34e-06	9.82e-05	CcSEcCtD
Epirubicin—Tachycardia—Doxorubicin—testicular cancer	4.32e-06	9.79e-05	CcSEcCtD
Epirubicin—Skin disorder—Doxorubicin—testicular cancer	4.3e-06	9.74e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Doxorubicin—testicular cancer	4.28e-06	9.7e-05	CcSEcCtD
Epirubicin—Anorexia—Doxorubicin—testicular cancer	4.22e-06	9.56e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Methotrexate—testicular cancer	4.22e-06	9.54e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—testicular cancer	4.18e-06	9.47e-05	CcSEcCtD
Epirubicin—Hypotension—Doxorubicin—testicular cancer	4.14e-06	9.37e-05	CcSEcCtD
Epirubicin—Urticaria—Methotrexate—testicular cancer	4.07e-06	9.2e-05	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—testicular cancer	4.05e-06	9.16e-05	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—testicular cancer	4.05e-06	9.16e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.04e-06	9.14e-05	CcSEcCtD
Epirubicin—Insomnia—Doxorubicin—testicular cancer	4.01e-06	9.07e-05	CcSEcCtD
Epirubicin—Paraesthesia—Doxorubicin—testicular cancer	3.98e-06	9.01e-05	CcSEcCtD
Epirubicin—Dyspnoea—Doxorubicin—testicular cancer	3.95e-06	8.94e-05	CcSEcCtD
Epirubicin—Somnolence—Doxorubicin—testicular cancer	3.94e-06	8.92e-05	CcSEcCtD
Epirubicin—Dyspepsia—Doxorubicin—testicular cancer	3.9e-06	8.83e-05	CcSEcCtD
Epirubicin—Decreased appetite—Doxorubicin—testicular cancer	3.85e-06	8.72e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Doxorubicin—testicular cancer	3.83e-06	8.66e-05	CcSEcCtD
Epirubicin—Fatigue—Doxorubicin—testicular cancer	3.82e-06	8.65e-05	CcSEcCtD
Epirubicin—Constipation—Doxorubicin—testicular cancer	3.79e-06	8.58e-05	CcSEcCtD
Epirubicin—Pain—Doxorubicin—testicular cancer	3.79e-06	8.58e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Methotrexate—testicular cancer	3.77e-06	8.53e-05	CcSEcCtD
Epirubicin—Asthenia—Methotrexate—testicular cancer	3.67e-06	8.31e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Doxorubicin—testicular cancer	3.65e-06	8.26e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Doxorubicin—testicular cancer	3.62e-06	8.2e-05	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—testicular cancer	3.62e-06	8.19e-05	CcSEcCtD
Epirubicin—Urticaria—Doxorubicin—testicular cancer	3.52e-06	7.97e-05	CcSEcCtD
Epirubicin—Abdominal pain—Doxorubicin—testicular cancer	3.5e-06	7.93e-05	CcSEcCtD
Epirubicin—Body temperature increased—Doxorubicin—testicular cancer	3.5e-06	7.93e-05	CcSEcCtD
Epirubicin—Diarrhoea—Methotrexate—testicular cancer	3.5e-06	7.93e-05	CcSEcCtD
Epirubicin—Dizziness—Methotrexate—testicular cancer	3.38e-06	7.66e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Doxorubicin—testicular cancer	3.26e-06	7.39e-05	CcSEcCtD
Epirubicin—Vomiting—Methotrexate—testicular cancer	3.25e-06	7.36e-05	CcSEcCtD
Epirubicin—Rash—Methotrexate—testicular cancer	3.23e-06	7.3e-05	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—testicular cancer	3.22e-06	7.3e-05	CcSEcCtD
Epirubicin—Headache—Methotrexate—testicular cancer	3.21e-06	7.26e-05	CcSEcCtD
Epirubicin—Asthenia—Doxorubicin—testicular cancer	3.18e-06	7.2e-05	CcSEcCtD
Epirubicin—Pruritus—Doxorubicin—testicular cancer	3.14e-06	7.1e-05	CcSEcCtD
Epirubicin—Nausea—Methotrexate—testicular cancer	3.04e-06	6.88e-05	CcSEcCtD
Epirubicin—Diarrhoea—Doxorubicin—testicular cancer	3.03e-06	6.86e-05	CcSEcCtD
Epirubicin—Dizziness—Doxorubicin—testicular cancer	2.93e-06	6.63e-05	CcSEcCtD
Epirubicin—Vomiting—Doxorubicin—testicular cancer	2.82e-06	6.38e-05	CcSEcCtD
Epirubicin—Rash—Doxorubicin—testicular cancer	2.79e-06	6.32e-05	CcSEcCtD
Epirubicin—Dermatitis—Doxorubicin—testicular cancer	2.79e-06	6.32e-05	CcSEcCtD
Epirubicin—Headache—Doxorubicin—testicular cancer	2.78e-06	6.28e-05	CcSEcCtD
Epirubicin—Nausea—Doxorubicin—testicular cancer	2.63e-06	5.96e-05	CcSEcCtD
